DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+14.86%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.58B
AUM Growth
+$2.58B
(+6.7%)
Cap. Flow
-$223M
Cap. Flow
% of AUM
-8.64%
Top 10 Holdings %
Top 10 Hldgs %
35.34%
Holding
118
New
12
Increased
13
Reduced
28
Closed
12
Top Buys
| 1 |
Gilead Sciences
GILD
|
$81.7M |
| 2 |
McKesson
MCK
|
$34M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$29.4M |
| 4 |
AnaptysBio
ANAB
|
$23.5M |
| 5 |
LOXO
Loxo Oncology, Inc
LOXO
|
$21.1M |
Top Sells
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$126M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$60.8M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$47.3M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$32.6M |
| 5 |
Humana
HUM
|
$26.6M |
Sector Composition
| 1 | Healthcare | 71.6% |
| 2 | Financials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVXS
1
DELISTED
AveXis, Inc. Common Stock
AVXS
| $170M | 6.56% | 2,236,701 | – | – |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $162M | 6.24% | 10,944,988 +1,988,000 | +22% | +$29.4M |
|
|
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
| $100M | 3.87% | 3,744,151 -514,045 | -12% | -$13.8M |
|
|
4
Gilead Sciences
GILD
$140B
| $81.7M | 3.15% | +1,203,000 | New | +$81.7M |
|
5
Viatris
VTRS
$12.3B
| $79.6M | 3.07% | 2,042,224 +275,846 | +16% | +$10.8M |
|
|
DBVT
6
DBV Technologies
DBVT
$264M
| $61.4M | 2.37% | 1,743,229 | – | – |
|
|
PTLA
7
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $56.9M | 2.19% | 1,451,301 -3,203,146 | -69% | -$126M |
|
|
BPMC
8
DELISTED
Blueprint Medicines
BPMC
| $54.6M | 2.11% | 1,365,000 -477,415 | -26% | -$19.1M |
|
9
Elevance Health
ELV
$71.8B
| $52.6M | 2.03% | 318,000 | – | – |
|
|
GWPH
10
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $51.5M | 1.98% | 425,545 -502,647 | -54% | -$60.8M |
|
11
Centene
CNC
$14.3B
| $43M | 1.66% | 603,643 | – | – |
|
|
LCI
12
DELISTED
Lannett Company, Inc.
LCI
| $41.4M | 1.6% | 1,853,896 -153,655 | -8% | -$3.43M |
|
|
AVDL
13
Avadel Pharmaceuticals
AVDL
$1.43B
| $39.4M | 1.52% | 4,072,809 | – | – |
|
14
Editas Medicine
EDIT
$231M
| $38.2M | 1.47% | 1,709,400 | – | – |
|
|
NVRO
15
DELISTED
NEVRO CORP.
NVRO
| $37.8M | 1.46% | 402,998 -348,300 | -46% | -$32.6M |
|
|
AERI
16
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $36.1M | 1.39% | 795,743 -1,043,086 | -57% | -$47.3M |
|
|
AET
17
DELISTED
Aetna Inc
AET
| $34.1M | 1.31% | 267,000 +25,000 | +10% | +$3.19M |
|
|
18
McKesson
MCK
$85.4B
| $34M | 1.31% | +229,000 | New | +$34M |
|
|
MNK
19
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $32.5M | 1.25% | 728,949 +321,949 | +79% | +$14.3M |
|
20
Vanda Pharmaceuticals
VNDA
$279M
| $32.2M | 1.24% | 2,299,046 -1,125,630 | -33% | -$15.8M |
|
21
eHealth
EHTH
$118M
| $31.8M | 1.23% | 2,640,609 | – | – |
|
|
LOXO
22
DELISTED
Loxo Oncology, Inc
LOXO
| $31.7M | 1.22% | 753,300 +502,300 | +200% | +$21.1M |
|
23
Xencor
XNCR
$580M
| $30.7M | 1.19% | 1,284,758 -735,242 | -36% | -$17.6M |
|
|
WBA
24
DELISTED
Walgreens Boots Alliance
WBA
| $29.6M | 1.14% | 355,957 | – | – |
|
|
UAM
25
DELISTED
Universal American Corp
UAM
| $28.3M | 1.09% | 2,833,531 -940,559 | -25% | -$9.38M |
|